Provided by Tiger Trade Technology Pte. Ltd.

IDEXX Laboratories

660.71
+3.330.51%
Post-market: 660.710.00000.00%16:37 EST
Volume:414.31K
Turnover:273.10M
Market Cap:52.76B
PE:50.51
High:666.14
Open:657.57
Low:650.00
Close:657.38
52wk High:769.98
52wk Low:356.14
Shares:79.85M
Float Shares:79.12M
Volume Ratio:0.86
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):13.08
EPS(LYR):13.08
ROE:66.20%
ROA:25.59%
PB:32.86
PE(LYR):50.51

Loading ...

Is It Too Late To Consider IDEXX Laboratories (IDXX) After Strong Multi‑Year Share Price Gains?

Simply Wall St.
·
Yesterday

IDEXX Laboratories Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 25

Is IDEXX’s (IDXX) Board Transition Shaping Its Strategy Around InVue DX and Recurring Revenue?

Simply Wall St.
·
Feb 23

IDEXX FY 2025 CAG Diagnostics capital instrument revenue jumps 51.8% to USD 200.21 million

Reuters
·
Feb 21

IDEXX Director Sophie V. Vandebroek Disposes of Common Shares

Reuters
·
Feb 20

IDEXX Laboratories Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 19

IDEXX Laboratories Announces Retirement of Director M. Anne Szostak and Appointment of Michael G. Erickson to Board

Reuters
·
Feb 14

IDEXX Laboratories Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 14

Should Strong 2025 Results and 2026 Outlook for CAG Diagnostics Recurring Revenue Require Action From IDEXX Laboratories (IDXX) Investors?

Simply Wall St.
·
Feb 13

IDEXX Laboratories Executives to Present at Major Investor Conferences

Reuters
·
Feb 13

Revvity Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Feb 12

IDEXX Laboratories Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 11

IDEXX Labs Is Maintained at Neutral by Piper Sandler

Dow Jones
·
Feb 10

Piper Sandler Adjusts Price Target on IDEXX Laboratories to $750 From $775, Maintains Neutral Rating

MT Newswires Live
·
Feb 09

Idexx Laboratories price target lowered to $750 from $775 at Piper Sandler

TIPRANKS
·
Feb 09

IDEXX Labs Is Maintained at Overweight by Barclays

Dow Jones
·
Feb 06

Barclays Lowers Price Target on IDEXX Laboratories to $800 From $850

MT Newswires Live
·
Feb 05

Piper Sandler Appoints Stuart Essig to Board of Directors

Reuters
·
Feb 04

IDEXX Laboratories Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Feb 04

IDEXX Laboratories Inc : Jefferies Cuts Target Price to $820 From $830

THOMSON REUTERS
·
Feb 03